forum health semaglutide & tirzepatide are transforming diabetes & obesity management. These GLP-1 receptor agonists offer benefits from glycemic control to weight loss and cardiovascular risk reduction, emphasizing their broad impact. Read more from Oral Semaglutide Gets FDA Approval
Description
Eli Lilly, makers of weight loss injection Zepbound, could soon be making its GLP-1 drug in pill form.
31% of GLP-1 users drank less alcohol in the past year
Discover how Calibrates Metabolic Reset pairs GLP-1 meds with expert coaching and lifestyle changes
One in five adults is considering GLP-1 medications for weight loss
Learn the signs, symptoms, and when to seek medical advice for your health
